Skip to main content
Skip to main content
Go to homepage

Pediatric Infectious Disease


By Eric Robinette, MD, MPH, Scott Pangonis, MD, MS, FAAP, and Shankar Upadhyayula, MD, Pediatric Infectious Disease Physician; , Akron Children's Hospital, Akron, OH

Infectious Disease

More about Eric Robinette, MD, MPH
More about Scott Pangonis, MD, MS, FAAP
More about Shankar Upadhyayula, MD

Objectives (Educational Content) :

1. Identify the clinical, laboratory and imaging findings of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19. 2. Describe the basic science of the various COVID-19 vaccines that are approved, authorized or in advanced development. 3. Recognize the growth incidence of Lyme disease in Ohio and identify when chemoprophylaxis is indicated following a tick bite.

Target Audience:

General pediatricians, family physicians, nurse practitioners, physician assistants, social workers, psychologists, and nurses.

Identified Gap:

Diagnosing and treating infectious diseases remains a large part of the primary care provider's workload. A yearly review of recently published literature will address knowledge gaps related to this patient care. We will address this topic and the gaps in diagnosis and treatment of MIS-C related to COVID and discuss the changing history of the COVID vaccine. With the increase of numbers of Lyme Disease cases being referred to the Infectious Disease department the timing for this topic to be addressed.

Estimated Time to Complete the Educational Activity:

1 hour

Expiration Date for CME Credit:


Method of Physician Participation in the Learning Process:

The learner will view the presentation, successfully complete a post-test and complete an activity evaluation.

Evaluation Methods:

All learners must successfully complete a post-test, as well as an activity evaluation, to claim CME credit.


Dr. Robinette, Dr. Pangonis and Dr. Upadhyayula has indicated that he has no relevant financial or other relationships with any commercial interests.

Accreditation Statement:

Children’s Hospital Medical Center of Akron is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.

CHMCA designates this enduring material activity for a maximum of 3.0 AMA PRA Category 1 Credit TM.  Physicians should only claim the credit commensurate with the extent of their participation in the activity. 


Science Brief: COVID-19 Vaccines and Vaccination. July, 27, 2021. Accessed 8/13/21

Reduced Risk of Reinfection with SARS-COV-2 After COVID-19 Vaccination – Kentucky, May-June 2021. August 13, 2021. Accessed 8/13/21

Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals. August 12, 2021. Accessed 8/13/21

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices – United States, June 2021. July 9, 2021. Accessed 8/13/21

Hospitalization of Adolescents Aged 12-17 years with Laboratory-Confirmed COVID-19 – COVID-NET, 14 states, March 1,2020-April 24, 2021. June 11, 2021. Accessed 8/13/21

Dufort EM, Koumans EH, Chow EJ, et al. Multisystem inflammatory syndrome in children in New York state. N Engl J Med. 2020;383(4):347-358. doi:10.1056/NEJMoa2021756

Jiang L, Tang K, Levin M, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020;20(11):e276-e288. doi:10.1016/S1473-3099(20)30651-4

Carter MJ, Shankar-Hari M, Tibby SM. Paediatric Inflammatory Multisystem Syndrome Temporally-Associated with SARS-CoV-2 Infection: An Overview. Intensive Care Med. 2021;47(1):90-93. doi:10.1007/s00134-020-06273-2

Henderson LA, Canna SW, Friedman KG, et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 1. Arthritis Rheumatol. 2020;72(11):1791-1805. doi:10.1002/art.41454

Dufort EM, Koumans EH, Chow EJ, et al. Multisystem inflammatory syndrome in children in New York state. N Engl J Med. 2020;383(4):347-358. doi:10.1056/NEJMoa2021756

Jonat B, Gorelik M, Boneparth A, et al. Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019 in a Children’s Hospital in New York City. Pediatr Crit Care Med. 2020;Publish Ahead of Print:1-14. doi:10.1097/pcc.0000000000002598\

Consiglio CR, Cotugno N, Sardh F, et al. Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell. 2020;183(4):968-981.e7. doi:10.1016/j.cell.2020.09.016

Gruber CN, Patel RS, Trachtman R, et al. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C). Cell. 2020;183(4):982-995.e14. doi:10.1016/j.cell.2020.09.034

Brodsky NN, Ramaswamy A, Lucas CL. The Mystery of MIS-C Post-SARS-CoV-2 Infection. Trends Microbiol. 2020;28(12):956-958. doi:10.1016/j.tim.2020.10.004

Danziger-Isakov L. Infections in Children on Biologics. Infect Dis Clin North Am. 2018;32(1):225-236. doi:10.1016/j.idc.2017.10.004